At GTC: Bristol Myers Squibb brings Boltz models into drug discovery workflows
GabriCorso · x · 2026-10-22
At GTC, the Boltz team announced a collaboration with Bristol Myers Squibb to bring the latest Boltz models into BMS's drug discovery workflows. Commenters see it as a textbook case of organic open-source model adoption growing into a deeper commercial partnership.
More from Companies & People
- Anthropic Publishes Its First Annual Public Benefit Report With Five Pillars — AnthropicAI · 2026-10-22
- Engineer says Apple has cold-emailed him 4 times in a month with info not on his LinkedIn — teodorio · 2026-10-22
- Pretraining researcher Yingbo Zhou unveils Flint's first model — ChengleiSi · 2026-10-22
- OpenAI details ChatGPT's ad stack: LLM orchestrator, retrieval, ranking and auction tools — OpenAIDevs · 2026-10-22
- Hiring at high-performance orgs shifts from quantity to quality as AI agents amplify output — andreisavu · 2026-10-22
- 9th Michigan AI Symposium draws over 400 attendees from across the region — radamihalcea · 2026-10-22